Re:John Ioannidis Aims His Bazooka at Nutrition Science (2018)
by aaavl2821 on Friday March 08, 2019 @12:36PM
(#19339842)
That's a widely criticized study because it ignores the cost of failure. It only looks at the r&d investments of companies that received FDA approval for a drug. It's like doing a study of the odds of winning the lottery, and only analyzing people who won the lottery
Considering the fact that 90% of phase 1 drugs never get approved and that study seems quite biased. That study conveniently assumes that all those medicinal chemists, who've worked decades and never seen a drug approved, simply don't exist
Sounds nice, the best evidence we have disagrees: https://news.ohsu.edu/2017/09/11/how-much-does-it-cost-to-br...